Cannabis Investing Newsletter

Learn To Pick The Best Cannabis Stocks

Cannabis Stocks Forum & Discussion

Welcome to the Cannabis Investing Newsletter Forum. This is for the cannabis stocks forum & discussion. Feel free to find your favorite cannabis stocks and contribute content as you please; content that continues the discussion of, and analysis of, cannabis stocks. – D. H. Taylor

Clear all

[Sticky] Aleafia Health ALEAF Stock Forecast & Analysis

D. H. Taylor
Member Admin
Joined: 2 years ago
Posts: 703
Topic starter  

Aleafia Health ALEAF stock is taking a slightly different approach to cannabis.  And, I wanted to highlight Aleafia Health as one of your cannabis investments in your portfolio.  Is ALEAF stock a good investment depends on your objectives.  For me, I get what they are doing and I could see the potential opportunity.  But, I…

This topic was modified 2 months ago by D. H. Taylor

Ronnie Silva
New Member
Joined: 6 months ago
Posts: 4

A recent Update frpom ALEAF >> Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth

Aleafia Health Continues to Gain Share in Adult Use Cannabis Market and Drive International Sales Growth
Reached new record market share overall adult use market share of 2.06% in February 2022, advancing 33% from 1.54% in November 2021(1)
Continued ascent in overall market share rankings, up two more notches to 13th in February 2022 from 15th in November 2021
On the pathway towards a top 10 market share position by the end of 2022
Received first $1 million purchase order
Secured seven new listings in Ontario and six in Alberta to enter market in the Spring
International POs in hand already exceed entire second half of 2021
Headed towards break-even Adjusted EBITDA profitability in second half of 2022
TORONTO, March 25, 2022 – Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to provide a corporate update demonstrating that the Company continues to deliver market share advances by focusing on the highest revenue generating dried flower, pre-roll, and vape product categories. Consumers continue to express strong interest in its Sunday Market House of Brands adult-use cannabis products in these categories.

“In February, the Company reported that it had changed the business’ strategy towards being a branded cannabis products provider, with branded cannabis representing 80% of total net revenue in 2021 compared to 33% in 2020,” said Aleafia Health CEO Tricia Symmes. “Now we continue to deliver on that strategy, with record growth in market share in February and unique product introductions that demonstrate the success of our Sunday Market House of Brands, setting the stage for future success in the highest volume cannabis categories.”

In February, Aleafia Health achieved record 2.06% adult use market share in four major markets, advancing 33% from 1.54% in November 2021. In the same time frame, market share in flower rose to 1.86% from 1.47%, pre-rolls rose to 2.62% from 2.09%, vapes rose to 2.18% from 0.92%, and oil rose to 4.01% from 2.68%.(1) These advances in market share would have been stronger absent temporary capacity limitations at the Company’s Grimsby greenhouse facility.

Among Canadian LPs, in its four major markets, the Company ranked in February 2022(1):
○ 13th overall, up from 30th in February 2021
○ 11th in pre-rolls, up from 37th in February 2021
○ 11th in vapes, up from 18th in February 2021

This 17-position overall market share rank increase, from 30th to 13th, demonstrates the success of the Sunday Market House of Brands. This growth was driven by strong retail pull-through of the Divvy product portfolio, Sunday Market’s everyday brand. The Company recently shipped its first flower SKUs to British Columbia, including 14g bags of Divvy Sour Kush and Flo, and 3.5g bags of Divvy Black Widow CBD, the Company’s spicy balanced flower offering. Divvy has consistently been one of the top 12 most searched brands on since its first product launch in April 2021. In addition, the Company’s Kin Slips discrete sublingual strip brand ranks #1 in Ontario.
As another indicator of consumer demand and sales momentum for adult use products, the Company for the first time has received a $1 million purchase order from Ontario, covering a wide range of products. In addition, Aleafia Health has secured purchase orders in 2022 year-to-date from Australia and Europe that exceed 2021 second half sales to international markets. Aleafia continues to target international sales as a future growth area, benefitting from its strong relationships with overseas distributors.
“Many of the Company’s new listings are line extensions, which speak volumes about the confidence the OCS and AGLC have in the Company, as those provincial authorities usually list line extensions only if predecessor products have been successful, which ours clearly were.”
“Divvy, the Company’s well-established everyday brand is focused on an exceptional value proposition, with a full suite of dried flower, pre-rolls, vapes and cannabis derivative products, benefitting from supply agreements with Ontario, Alberta, Saskatchewan, British Columbia,” Symmes said. “The Company has more than 100 provincial listings and seven new SKUs in Ontario and six in Alberta this Spring. That continued revenue velocity, in combination with the continued cost containment and rationalization initiatives underway, is helping drive us towards achieving breakeven Adjusted EBITDA(2) profitability in the second half of 2022.”

1. Based on HiFyre data for Ontario, Alberta, British Columbia and Saskatchewan markets.
2. Please see "Adjusted EBITDA" section of the Company’s MD&A dated February 14, 2022 for reconciliation to IFRS equivalent.

For Investor & Media Relations:

Matthew Sale, CFO

I Personally have a medium Position in ALEAF W/ 1380 shares, Bought mostly Below 0.20 and as Low as 0.095


Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 10MB

Preview 0 Revisions Saved

Copyright Cannabis Investing Newsletter 2021 - 2022